SON expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.938400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.042200E-01
Normal-vs-Stage2
3.898000E-01
Normal-vs-Stage3
2.595800E-01
Normal-vs-Stage4
3.971800E-01
Stage1-vs-Stage2
3.353400E-01
Stage1-vs-Stage3
1.864370E-02
Stage1-vs-Stage4
3.324800E-01
Stage2-vs-Stage3
1.539640E-01
Stage2-vs-Stage4
9.830800E-01
Stage3-vs-Stage4
8.788300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.935200E-01
Normal-vs-AfricanAmerican
3.517600E-01
Normal-vs-Asian
3.357400E-01
Caucasian-vs-AfricanAmerican
3.383200E-01
Caucasian-vs-Asian
3.305200E-01
AfricanAmerican-vs-Asian
2.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.983200E-01
Normal-vs-Female
3.908000E-01
Male-vs-Female
8.387000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.890800E-01
Normal-vs-Age(41-60Yrs)
4.646800E-01
Normal-vs-Age(61-80Yrs)
3.645800E-01
Normal-vs-Age(81-100Yrs)
3.567200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.435200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.693400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.565590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.942410E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.051160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.878400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.807800E-01
Normal-vs-Daily Drinker
2.988400E-01
Normal-vs-Weekly Drinker
3.630800E-01
Normal-vs-Occasional Drinker
4.555000E-01
Normal-vs-Social Drinker
4.425800E-01
Non Drinker-vs-Daily Drinker
1.165180E-01
Non Drinker-vs-Weekly Drinker
7.591800E-01
Non Drinker-vs-Occasional Drinker
3.330000E-01
Non Drinker-vs-Social Drinker
4.825800E-01
Daily Drinker-vs-Weekly Drinker
3.507200E-01
Daily Drinker-vs-Occasional Drinker
2.167500E-02
Daily Drinker-vs-Social Drinker
5.599600E-02
Weekly Drinker-vs-Occasional Drinker
3.099800E-01
Weekly Drinker-vs-Social Drinker
4.352800E-01
Occasional Drinker-vs-Social Drinker
8.801000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.433800E-02
Normal-vs-Grade 2
7.678600E-03
Normal-vs-Grade 3
6.164200E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.404600E-01
Grade 1-vs-Grade 3
6.815000E-01
Grade 1-vs-Grade 4
7.433800E-02
Grade 2-vs-Grade 3
5.683400E-01
Grade 2-vs-Grade 4
7.678600E-03
Grade 3-vs-Grade 4
6.164200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.404000E-01
Normal-vs-NonDiabetic
3.876800E-01
Diabetic-vs-NonDiabetic
2.181400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.939400E-01
Normal-vs-NoPancreatitis
3.788000E-01
Pancreatitis-vs-NoPancreatitis
8.841000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.110000E-01
Normal-vs-N1
3.873800E-01
N0-vs-N1
5.902600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.174800E-01
Normal-vs-TP53-NonMutant
5.024200E-01
TP53-Mutant-vs-TP53-NonMutant
1.607570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
